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Abstract 
 
The effect of different levels of progesterone 
(P4) concentrations on follicle growth and ovulatory 
capacity was evaluated in 40 crossbred Bos indicus x 
Bos taurus cyclic heifers submitted to distinct PGF2α 
+ progesterone-based protocols. Heifers in CIDR_PGF8 
group (n = 10) received 2.0 mg i.m. estradiol benzoate 
(EB) and a new controlled internal drug release 
containing 1.9 g of progesterone (CIDR) on day 0 of 
study. At the time of CIDR withdrawal (day 8), heifers 
received an i.m. injection of PGF2α and 24 h later a 
second EB i.m. injection (0.5 mg). The three other 
groups received EB injections and CIDR 
insertion/withdrawal as aforementioned, except that an 
i.m. injection of PGF2α was administered on day 5. In 
addition, heifers in the CIDR_PGF5 group (n = 10) 
received a new CIDR, while heifers in the 
CIDR1x_PGF5 (n = 9) and CIDR2x_PGF5 (n = 11) 
groups received a previously used CIDR for 8 and 14 
days, respectively. Heifers that received a PGF2α 
injection on day 5 showed lower circulating P4 than 
heifers treated on day 8 (CIDR_PGF5 = 1.98 ± 0.21 
ng/ml; CIDR1x_PGF5 = 1.69 ± 0.17 ng/ml and 
CIDR2x_PGF5 = 1.33 ± 0.08 ng/ml versus 
CIDR_PGF8 = 3.31 ± 0.45 ng/ml). The dominant 
follicle (DF) growth rate was slower in those heifers 
receiving PGF2α injection on day 8 (CIDR_PGF8 = 
0.72 ± 0.13 mm/day) than groups treated on day 5 
(CIDR_PGF5 = 0.96 ± 0.12 mm/day; CIDR1x_PGF5 = 
1.06 ± 0.15 mm/day and CIDR2x_PGF5 = 1.01 ± 0.06 
mm/day). In consequence, preovulatory follicle 
diameter on day 10 was smaller in those animals 
injected on day 8 (CIDR_PGF8 = 8.81 ± 6.7 mm) than 
in those treated on day 5 (CIDR_PGF5 = 10.00 ± 
0.58 mm CIDR1x_PGF5 = 10.5 ± 0.69 mm and 
CIDR2x_PGF5 = 10.5 ± 0.35 mm). For heifers 
receiving PGF2α injection on day 5, no significant 
differences on plasma P4 concentrations, follicular 
growth rate and DF diameters were observed among 
heifers that received new or previously used CIDR 
inserts. These results suggest that the presence of corpus 
luteum during synchronization protocols is the main 
factor responsible for the increase in the plasma P4 
concentrations and inhibition of DF growth.  
Keywords: follicle, ovulation, progesterone, 
prostaglandin.  
 
Introduction 
 
Artificial insemination (AI) and embryo 
transfer (ET) programs have been employed worldwide 
in cattle, however, estrous detection remains one of the 
main limiting factors to implement such technologies 
(Baruselli et al., 2004). Based on the in-depth 
knowledge of cows’ ovarian and hormonal activities, 
protocols for timed artificial insemination (TAI) and 
timed embryo transfer (TET) have been developed over 
the past years to overcome the challenges associated 
with estrous detection, representing a feasible tool to 
improve results of these programs (Peters and Pursley, 
2003; Baruselli et al., 2004; Dias et al., 2009). 
High circulating P4 concentrations have been 
associated with decreased growth of the dominant 
follicle (Stock and Fortune, 1993; Bergfeld et al., 1995) 
as high concentrations of this hormone lead to the 
decrease of LH pulse frequency and, therefore, 
suppresses dominant follicle (DF) growth in cattle 
(Kinder et al., 1996). Thus, lower circulating 
progesterone concentrations during progesterone-based 
protocols associated with estrogen at the beginning of 
treatment might increase follicular growth during the 
synchronization period, with further improvements in 
both ovulation and conception rates. 
In this regard, ovulatory follicles of smaller 
diameters have been related to ovulation failures and 
delayed ovulation due to the presence of immature 
follicles that are unresponsive to the LH surge. 
Consequently, attempts have been made to improve 
ovulation and pregnancy rate by increasing the size of 
the ovulatory follicle in TAI (Vasconcelos et al., 2001) 
and TET programs (Baruselli et al., 2001; Mantovani et 
al., 2005). Moreover, increasing preovulatory follicle 
size is a strategy to increase the size of subsequent 
corpus luteum (CL) with higher progesterone-secreting 
capacity (Pfeifer et al., 2009) to maintain the early 
pregnancy (Binelli et al., 2001).  
Based on the aforementioned facts, this 
experiment was designed to evaluate the effect of different 
levels of P4 exposure on follicle growth and ovulatory 
capacity in Bos indicus x Bos taurus crossbred heifers 
submitted to PGF2α/progesterone-based protocols.  
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Materials and Methods 
 
Location, animals and feeding 
 
The experiment was conducted on a 
commercial beef farm located in Southeastern Brazil. 
Forty crossbred Bos indicus x Bos taurus (½ Nelore x ½ 
Simental) cyclic heifers, (previously confirmed by heat 
detection), 20 to 24 months old and presenting body 
condition score (BCS) from 2.5 to 3.5 (within a 1 to 5 
scale; according to Houghton et al., 1990) were selected 
for the study. Heifers were kept in Brachiaria 
decumbens pasture with free access to mineral 
supplement and water. Numbered ear tags were used for 
animal identification. All animal procedures were 
approved by the Animal Care Committee of the Faculty 
of Veterinary Medicine and Husbandry, Universidade 
de São Paulo, São Paulo, SP, Brazil. 
 
Hormonal treatments  
 
All heifers were pre-synchronized with two 
i.m. injections of PGF2α (25 mg of dinoprost 
tromethamine - Lutalyse, Pfizer Animal Health, São 
Paulo, SP, Brazil) 12 days apart (day - 24 and day - 12). 
The objective was to synchronize estrus such that 
heifers would be in diestrus at the beginning of 
treatment with an intravaginal source of P4.  
On day 0, all heifers presented a CL observed 
by ultrasonoghrafic examination. At this time, heifers 
were randomly allocated to one of four treatments with the 
intravaginal sources, as demonstrated in the experimental 
design (Fig. 1). Heifers in the CIDR_PGF8 group (n = 10) 
received 2.0 mg i.m. estradiol benzoate (EB - Estrogin, 
Farmavet, São Paulo, SP, Brazil) and a new controlled 
internal drug release containing 1.9 g of progesterone 
(CIDR, Pfizer Animal Health, Brazil). On day 8, at the 
time of CIDR withdrawal, heifers received an i.m. 
injection of PGF2α and, on day 9, an injection of 0.5 mg 
of EB i.m. Other groups received EB i.m. injections and 
CIDR insertion/withdrawal as aforementioned, except 
that an i.m. injection of PGF2α was administered on 
day 5. Nevertheless, heifers in the CIDR_PGF5 group 
(n = 10) received a new CIDR, while heifers in the 
CIDR1 x_PGF5 (n = 9) and CIDR2x_PGF5 (n = 11) 
groups received a previously used CIDR for 8 and 14 days, 
respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic diagram of experiment. Pre-synchronization with two injections of PGF2α twelve days apart. 
Ovarian ultrasound evaluations (US) were performed every 24 h from day 5 to day 8, and every 12 h from day 9 to 
day 12. Blood samples (BS) were collected daily from day 6 to day 9. 
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Ultrasound examinations 
 
Heifers were submitted to ultrasound 
examination at day 0 to confirm the presence of CL at 
beginning of the estrous synchronization protocol. Then, 
heifers underwent daily transrectal ultrasound (US) 
examinations from day 5 to day 9 in order to evaluate 
the DF growth rate and, every 12 h from day 10 to day 
12, to establish the time of ovulation. US examinations 
were done always by the same technician, using a 100 
Vet US equipped with an 8 MHz linear-array transducer 
(Pie Medical, Netherlands). Follicular growth rate in 
each group was obtained by the difference in follicle 
mean diameter daily registered from day 5 to day 10. 
Ovulation was characterized by the disappearance of DF 
previously identified and the moment of ovulation was 
established as 6 h before the last ultrasound examination 
(Carvalho et al., 2008). The ovulation rate was 
determined by total of animals that had a synchronized 
ovulation following the ovarian synchronization 
protocol by the total of synchronized animals.  
 
Blood sampling and progesterone assay  
 
Blood samples from all heifers were collected 
into heparinized Vacutainer® tubes (Becton Dickinson 
Co., Franklin Lakes, NJ, USA) once daily from day 6 
to day 9 by jugular venipuncture. Afterwards, samples 
were centrifuged at 1600 x g for 20 min and the 
plasma stored at -20°C until radioimmunoassay (Coat-
A-Count, Diagnostic Products Corporation, Los 
Angeles, EUA). 
The P4 assay sensitivity was 0.07 ng/ml and 
the inter- and intra-assay coefficients of variation were 
6.7 and 9.0% respectively. Analysis was done at the 
Laboratório de Análise Hormonal, Universidade de São 
Paulo, SP, Brazil.  
 
Statistical analyses 
 
Data were statistically analyzed using SAS 
software (SAS Institute Inc., Cary, NC, USA). Initially, 
the statistical assumptions of homogeneity of variances 
and residue normality were verified and, whenever 
necessary, data were transformed in order to meet the 
assumptions. Log transformation was used for 
circulating progesterone to attain normality. 
Follicular growth in each group was calculated 
by the difference in follicle diameter daily registered 
from day 5 to 10. Punctual (plasma P4, follicular 
growth, interval from CIDR removal to ovulation and 
ovulation rate) and temporal (plasma P4 from day 6 to 
day 9, follicular diameter from day 5 to day 10) 
variables were evaluated using orthogonal contrast. 
Orthogonal comparisons were performed to determine 
the three main effects: day of reatment with PGF2α 
[CIDR_PGF8 vs. CIDR_PGF5 + CIDR1x_PGF5 + 
CIDR2x_PGF5], effect of the type (new or previously 
used) of the intravaginal progesterone device 
(CIDR_PGF5 vs. CIDR1x_PGF5 + CIDR2x_PGF5) and 
duration of used CIDR (CIDR1x_PGF5 vs. 
CIDR2x_PGF5). The orthogonal arrangements were used 
on the responses variables P4 concentration during CIDR 
treatment, follicular growth and ovulation rates. The 
effects of the different contrasts on the P4 concentration 
and the follicular growth were analyzed using repeated 
measures (PROC MIXED) and the ovulation rate was 
analyzed using the logistic regression (PROC Glimmix). 
Results were expressed as means ± SEM. 
Differences were considered significant when P < 0.05 
and tendencies when 0.1 > P ≥ 0.05. 
 
Results 
 
There was a significant effect of earlier 
administration of the PGF2α treatment on P4 
concentrations during CIDR treatment (P < 0.001; Table 
1) as heifers treated on day 5 showed lower mean 
circulating P4 from day 6 to day 8 than heifers treated 
on day 8 (CIDR_PGF5 = 1.98 ± 0.21 ng/ml, 
CIDR1x_PGF5 = 1.69 ± 0.17 ng/ml, and 
CIDR2x_PGF5 = 1.33 ± 0.08 ng/ml vs. CIDR_PGF8 
= 3.31 ± 0.45 ng/ml; Fig. 2). 
Treatment with PGF2α on day 5 also had a 
positive effect on DF growth rate between days 5 to 10, 
such that treatment with PGF2α on day 8 reduced 
(P < 0.05) the growth rate of the DF (CIDR_PGF8 = 
0.72 ± 0.13 mm/day) when compared to groups treated 
on day 5 (CIDR_PGF5 = 0.96 ± 0.12 mm/day; 
CIDR1x_PGF5 = 1.06 ± 0.15 mm/day, CIDR2x_PGF5 = 
1.01 ± 0.06 mm/day). As a consequence, heifers 
receiving a PGF2α injection on day 8 presented smaller 
DF diameter on day 10 (CIDR_PGF8 = 8.81 ± 6.7 mm) 
than those that received the same treatment on day 5 
(CIDR_PGF5 = 10.00 ± 0.58 mm, CIDR1x_PGF5 = 
10.5 ± 0.69 mm, CIDR2x_PGF5 = 10.5 ± 0.35 mm; 
P < 0.05; Fig. 3).  
As demonstrated in Table 1, there was a 
tendency (P = 0.09) for a longer interval from CIDR 
removal to ovulation in heifers that received an injection 
of PGF2α on day 8 (CIDR_PGF8 = 74 ± 6.2 h) when 
compared with heifers that received PGF2α on day 5 
(CIDR_PGF5 = 69 ± 8.5 h; CIDR1x_PGF5 = 66 ± 0 h 
and CIDR2x_PGF5 = 72 ± 6.3 h).  
In this experiment, ovulation rate among 
groups were not statistically different according to day 
of PGF2α treatment, the type of CIDR (new and 
previously used) or the duration of the previous use (8 
or 14 days), as shown in the Table 1. 
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Table 1. Plasma P4 concentrations from day 6 to day 8, follicular growth rate (mm/day) from day 5 to day 10 and 
interval from CIDR withdrawal to ovulation in heifers submitted to different PGF2α (day 5 or 8) plus P4 (new or 
previously used CIDRs) protocols. 
Item Treatmentsa Contrastsb 
 CIDR_PGF8 CIDR_PGF5 CIDR1x_PGF5 CIDR2x_PGF5 C1 C2 C3 
Serum P4 
concentration 
(ng/ml)c 
3.31 ± 0.45 1.98 ± 0.21 1.69 ± 0.17 1.33 ± 0.08 < 0.001 0.16 0.37 
Follicular 
growth rate 
(mm/day) 
0.72 ± 0.13 0.96 ± 0.12 1.06 ± 0.15 1.01 ± 0.06 0.04 0.61 0.78 
Interval from 
CIDR removal 
to ovulation (h) 
74 ± 6.2 69 ± 8.5 66 ± 0.0 72 ± 6.3 0.09 1.0 0.06 
Ovulation rate 
(%) 60.0 (6/10) 80.0 (8/10) 77.8 (7/9) 90.0 (10/11) 0.15 0.27 0.44 
a Treatments Groups:  
CIDR_PGF8: heifers were treated with a new CIDR and received a PGF2α treatment concurrent with the CIDR 
withdrawal on day 8;  
CIDR_PGF5: heifers were treated with a new CIDR and a PGF2α treatment was performed on day 5; CIDR was 
withdrawn on day 8; 
CIDR1x_PGF5: heifers received a previously used CIDR for 8 days and the PGF2α treatment was performed on day 
5; CIDR was withdrawn on day 8; 
CIDR2x_PGF5: heifers received a previously used CIDR for 14 days, PGF2α on day 5 and CIDR was withdrawn on day 8. 
bC1= Contrast of day of PGF2α treatment (CIDR_PGF8 vs. CIDR_PGF5 + CIDR1x_PGF5 + CIDR2x_PGF5);  
C2= Contrast of new vs. used CIDR (CIDR_PGF5 vs. CIDR1x_PGF5 + CIDR2x_PGF5);  
C3=Contrast of duration of used CIDR (CIDR1x_PGF5 vs. CIDR2x_PGF5); 
cSerum P4 concentration: mean of serum progesterone concentration from day 6 to day 8. 
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Figure 2. Plasma P4 profile between days 6 and 9 in heifers treated with PGF2α either on day 5 or day 8 and 
exposed to different levels of exogenous P4. Heifers that received PGF2α treatment on day 5 presented lower P4 
concentration (P < 0.001) than heifers treated only on day 8 (C1 = Contrast of day of PGF2α treatment: 
CIDR_PGF8 vs. CIDR_PGF5 + CIDR1x_PGF5 + CIDR2x_PGF5).  
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Figure 3. Dominant follicle diameter (mm) in heifers treated with PGF2α either on day 5 or day 8 and exposed to 
different levels of exogenous P4. Heifers that received PGF2α treatment on day 5 had larger dominant follicle 
growth (P = 0.04) than heifers treated only on day 8 (C1= Contrast of day of PGF2α treatment (CIDR_PGF8 vs. 
CIDR_PGF5 + CIDR1x_PGF5 + CIDR2x_PGF5). 
 
Discussion 
 
The current study showed that administration 
of a PGF2α analog on day 5 was effective in decreasing 
plasma concentrations of P4 and promoted an increased 
rate of follicular growth resulting in an ovulatory 
follicle with larger diameter, which is consistent with 
findings by others (Carvalho et al., 2008). 
The negative correlation between plasma P4 
concentrations and follicular development found in the 
current trial was consistent with those found in the study 
by Cupp et al. (1993) which reported that cows with 
lower circulating P4, approximately 1 to 2 ng/ml, 
developed follicles with higher diameters than those 
with higher circulating P4 concentrations (5 to 6 ng/ml).  
Additionally, other studies have demonstrated 
that high plasma P4 concentrations can affect LH 
pulsatility pattern as LH pulses occur in lower 
frequency in the presence of higher circulating P4  
(Ireland and Roche, 1982; Roberson et al., 1989), and 
the lower LH-pulse frequency is known to reduce 
follicular growth rate and consequently lower DF 
diameters (Kinder et al., 1996). Moreover, Cutaia et al. 
(2004) found higher ovulatory follicle size in beef cows 
receiving a PGF2α treatment at the time of P4-device 
insertion and supposed that lower P4 levels increased 
LH-pulse frequency, leading to higher DF growth. 
Similarly, Kinder et al. (1996) demonstrated that the use 
of a CIDR implant in the absence of a corpus luteum 
(CL) resulted in a sub-luteal plasma P4 concentration 
(1 to 2 ng/ml), which promoted greater frequency of LH 
pulses and consequently led to higher follicular 
diameter. 
Although LH pulses were not evaluated in the 
current study, it is very likely that greater LH 
frequencies accounted for the greater follicular growth 
rate found in heifers that had lower plasma P4 
concentrations due to PGF2α treatment on day 5.  
Considering a 3.1-day interval between EB 
treatment and the emergence of a new follicular wave 
(Bó et al., 1995; Burke et al., 2001) followed by 
follicular deviation approximately 2.6 days later 
(Gimenes et al., 2008), the PGF2α treatment on day 5 
ensured a lower circulating P4 by the time follicles’ 
gonadotropin dependency changed from FSH to LH. 
According to Baruselli et al. (2001), lower 
pregnancy responses following TAI programs applied to 
Bos indicus heifers and post partum cows can be, at 
least partially, attributed to ovulation failures due to 
small dominant follicle diameter at the time of expected 
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ovulation. In this regard, the PGF2α administration at 
the beginning of progesterone-based protocols could be 
a strategy to overcome this problem in cycling animals. 
In fact, Meneghetti et al. (2009) verified a positive 
effect on pregnancy rate to TAI when a PGF2α 
treatment was administered 48 h before CIDR 
withdrawal compared to the same treatment 
immediately after CIDR withdraw.  
Independently of the number of days the CIDR 
(new or previous used for 8 or 14 days was used), the 
groups that received PGF2α on day 5 presented lower 
plasma P4 concentration and higher follicular growth 
and DF diameter. These findings show that treatment 
with a P4-releasing device (both new or previously 
used) in the absence of a CL results in lower circulating 
P4 concentration of those found during the luteal phase 
that leads to higher follicular growth.  
Despite the greater diameter of DF in heifers 
with lower plasma P4, there was no statistical difference 
among groups’ ovulation rates in the current study. 
These findings could be partially attributed to the 
relatively small number of animals used in this trial, 
which is likely low for this type of analysis. Moreover, 
these results were not consistent with previous findings 
from Cutaia et al. (2004) and Carvalho et al. (2008) 
which observed that the treatment with PGF2α at the 
beginning of P4-based protocols increased ovulation 
rates. 
The tendency for a longer interval from CIDR 
removal to ovulation in heifers that received a PGF2α 
treatment on day 8 than in heifers that received on day 5 
might be attributed to a greater immature and 
unresponsive follicle as a result of higher plasma P4 
concentrations and lower follicular growth rate. 
Therefore, LH pulsatility was not only responsible for 
follicle growth, but potentially caused increased LH 
receptors in the DF (Lopez et al., 2005). Thus, greater 
circulating P4 might have decreased the frequency of 
LH pulses, leading to delayed expression of LH 
receptors in the DF and consequently time to ovulation. 
Results of the present study led to the 
conclusion that a PGF2α injection at early stages of P4-
based protocols (i.e day 5) may be a feasible alternative 
to increase DF growth rate and the diameter of the 
ovulatory follicle. This treatment could be an alternative 
to improve results of synchronization protocols both to 
IATF and ET programs. Moreover, results showed that 
CIDR can be satisfactory used for up to 3 times, without 
any impairment on follicular growth and on 
synchronization of ovulation.  
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